Regardless of whether it’s therapeutic or recreational purposes, CBD hemp has an endless potential when used properly. We at Swiss Hempcare are specialized in these applications, because Cannabinoids, especially Cannabidiol (CBD), are our heart and soul.
With a lot of passion, strict quality control and thorough monitoring of all processes, we are committed to return hemp to place it rightfully deserves in our society.
Products can only be marketed legally if they comply with the legislation of the country where it is placed on the market. Depending on the classification, the corresponding Swiss legislation is applied.
Products containing cannabidiol (CBD) are gaining popularity in Switzerland. Unlike THC (tetrahydrocannabinol), CBD is not subject to the Narcotics Act because it does not produce a comparable psychoactive effect. However, this does not mean that CBD can simply be added to random preparations at will or advertised arbitrarily.
This Information sheet provides an overview of the various CBD-containing raw materials and products offered by suppliers and their classification and marketability according to the current legal situation. It is intended primarily as an implementation guide for identifying the competent authorities and promoting consistent implementation. At the same time, it aims to raise awareness of the legal requirements among possible suppliers.
Grandmothers are replacing teas and infusions by CBD oils and creams creating a thriving market among the elderly.
However, from the medical point of view there is still ground to be covered. While even World Health Organization finds cannabidiol to be safe, posing no public health risk and having no potential for abuse , medical doctors are still skeptical. While seeing potential in the molecule for the treatment of several diseases, outside certain forms of epilepsy there is a lack of solid clinical data with most evidence coming from empirical observations, that vary wildly. Furthermore, some studies have shown that CBD can influence the levels of other drugs in the blood stream due to its effects in the liver activity, with a potential for liver toxicity demonstrated in some animal studies .
Posted on 8 January 2020 in Alcim’s articles by Charles Sagnes.